In the UK, over half of the population (55%) expect pharma companies to keep working together to develop better and more effective treatments in COVID-19 treatments and preventative care. Many are optimistic, including the 39% who believe that a better COVID-19 vaccination will be available in the near future. However, nearly a third (32%) are worried that the pandemic is causing researchers to sideline other key drug treatments and innovation in other areas of health.